CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Human Anti-Tumor Necrosis Factor Antibody Adalimumab in Crohn's Disease – First Results in Clinical Practice
DOI 10.1055/s-2006-955481
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Seiderer, S Brand, S Pfennig, C Tillack, B Göke, T Ochsenkühn
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe10/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Adalimumab (Humira; Abbott Laboratories, Chicago) represents a human IgG1 monoclonal antibody with high affinity binding and specificity to soluble human tumor necrosis factor (TNF). It has shown efficacy in patients with rheumatoid arthritis. So far, there is only limited clinical experience utilizing this antibody in patients with Crohn's disease (CD). Here we present our results on CD patients treat…
Zitieren
Zitierempfehlung
J Seiderer, S Brand, S Pfennig, C Tillack, B Göke, T Ochsenkühn (2006) Human Anti-Tumor Necrosis Factor Antibody Adalimumab in Crohn's Disease – First Results in Clinical Practice. Zeitschrift für Gastroenterologie (10). https://doi.org/10.1055/s-2006-955481
Mit CareLit weiterarbeiten